Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?

por Aguirre, Clara, Meca-Lallana, Virginia, Barrios-Blandino, Ana, del Río, Beatriz, Vivancos, Jose
Publicado 2020

Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial

por García-Vicuña, Rosario, Rodriguez-García, Sebastián C., Abad-Santos, Francisco, Bautista Hernández, Azucena, García-Fraile, Lucio, Barrios Blandino, Ana, Gutiérrez Liarte, Angela, Alonso-Pérez, Tamara, Cardeñoso, Laura, Alfranca, Aránzazu, Mejía-Abril, Gina, Sanz Sanz, Jesús, González-Alvaro, Isidoro
Publicado 2022